Cost cutting exercise and she probably thinks that concentrating on on trial will increase the chances of getting the HIV results out faster.
Not sure if they managed any success in either goal.
Your point is a good one - CIVID is the secondary line of research. In the last 12 months, the COVID space has become even more crowded - with the result that the competition has become much fiercer - prospects of a commercial deal much less likely.
Personally, I still think that the COVID trial was a bridge too far - and resources should have been applied purely to the HIV trials alone. They may have speeded up the release of the HIV results as well.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Cost cutting exercise and she probably thinks that concentrating...
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $51.43M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 24910 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.9¢ | 62000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24910 | 0.056 |
1 | 50000 | 0.055 |
2 | 52494 | 0.054 |
3 | 768657 | 0.053 |
4 | 485247 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.059 | 62000 | 1 |
0.060 | 465822 | 5 |
0.063 | 105621 | 2 |
0.065 | 46045 | 3 |
0.068 | 25200 | 2 |
Last trade - 07.02am 05/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
Day chart unavailable
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online